Colace Clear
Pricing Report NDC 67618-109-28

Latest NADAC: $0.24405 per EA · Effective Jul 17, 2019 · Est. package price $6.83 (28 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Colace Clear (NDC 67618-109-28) is $0.24405 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 17, 2019.

As a provided by Purdue Products Lp, this medication is distributed in a 1 BOTTLE in 1 CARTON / 28 CAPSULE, LIQUID FILLED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.24405
Per EA

Effective Date
Jul 17, 2019
Billable Units
28 EA
Estimated Package Price
$6.83
Data Status
As of Jul 31, 2019
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 28 CAPSULE, LIQUID FILLED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.23131 to $0.27304 per EA. Over this 4 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2313 - $0.2730
Market Volatility
18.04% Variance
Latest Trend
3.36%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 17, 2019 $0.24405 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2019 $0.25253 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2019 $0.25253 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 17, 2019 $0.24607 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 19, 2018 $0.25270 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 19, 2018 $0.25270 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Nov 21, 2018 $0.23936 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 17, 2018 $0.25132 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 20, 2018 $0.24589 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 20, 2018 $0.24589 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jun 20, 2018 $0.24589 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Apr 18, 2018 $0.25214 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026